The specific elevation of serum APOD protein was subsequently confirmed through orthogonal validation <i>via</i> ELISA in an independent cohort, where its levels were significantly higher in patients with early sarcopenia compared to healthy controls. The gene discussed is APOD; the disease is sarcopenia.